UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
Cognizant
CTSH
|
+$150M |
| 4 |
Chubb
CB
|
+$107M |
| 5 |
Under Armour
UAA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$221M |
| 2 |
Workday
WDAY
|
+$133M |
| 3 |
Pfizer
PFE
|
+$122M |
| 4 |
Apple
AAPL
|
+$122M |
| 5 |
Nike
NKE
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 14.7% |
| 3 | Financials | 13.4% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAS
626
DELISTED
AGL Resources Inc
GAS
| $20M | 0.02% |
306,758
+23,444
| +8% | +$1.51M |
|
|
GPOR
627
DELISTED
Gulfport Energy Corp.
GPOR
| $19.7M | 0.02% |
695,355
+190,695
| +38% | +$5.03M |
|
628
Unum
UNM
$14.1B
| $19.7M | 0.02% |
636,578
-15,224
| -2% | -$447K |
|
629
Leggett & Platt
LEG
$1.4B
| $19.6M | 0.02% |
405,887
-6,481
| -2% | -$281K |
|
630
Travel + Leisure Co
TNL
$4.77B
| $19.6M | 0.02% |
568,856
-41,226
| -7% | -$1.31M |
|
631
Jones Lang LaSalle
JLL
$17.2B
| $19.6M | 0.02% |
166,877
-21,204
| -11% | -$2.57M |
|
|
AFSI
632
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $19.5M | 0.02% |
752,965
+229,095
| +44% | +$6.09M |
|
|
AWH
633
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $19.4M | 0.02% |
554,134
-179,073
| -24% | -$6.14M |
|
634
Factset
FDS
$9.89B
| $19.3M | 0.02% |
127,671
-40,504
| -24% | -$6.04M |
|
635
AerCap
AER
$24.4B
| $19.3M | 0.02% |
498,517
+19,498
| +4% | +$671K |
|
636
Fortune Brands Innovations
FBIN
$6.24B
| $19.3M | 0.02% |
402,010
-280
| -0.1% | -$12K |
|
|
WRI
637
DELISTED
Weingarten Realty Investors
WRI
| $19.3M | 0.02% |
513,134
+48,822
| +11% | +$1.72M |
|
638
Icon
ICLR
$12.6B
| $19.1M | 0.02% |
+254,648
| New | +$17.8M |
|
|
PBCT
639
DELISTED
People's United Financial Inc
PBCT
| $19.1M | 0.02% |
1,198,264
-16,572
| -1% | -$249K |
|
640
Global Payments
GPN
$23.9B
| $19.1M | 0.02% |
292,122
-91,802
| -24% | -$5.44M |
|
|
RAD
641
DELISTED
Rite Aid Corporation
RAD
| $19M | 0.02% |
116,854
-24,185
| -17% | -$3.81M |
|
642
Jazz Pharmaceuticals
JAZZ
$17B
| $19M | 0.02% |
145,259
+12,328
| +9% | +$1.53M |
|
|
IFLN
643
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
| – | – |
0
| – | – |
|
|
IHS
644
DELISTED
IHS INC CL-A COM STK
IHS
| $18.8M | 0.02% |
151,186
-7,535
| -5% | -$803K |
|
645
Alexandria Real Estate Equities
ARE
$8.62B
| $18.6M | 0.02% |
204,856
-46,889
| -19% | -$3.82M |
|
|
RGLS
646
DELISTED
Regulus Therapeutics
RGLS
| $18.6M | 0.02% |
22,384
+209
| +0.9% | +$166K |
|
647
Norwegian Cruise Line
NCLH
$9.32B
| $18.6M | 0.02% |
335,755
-8,056
| -2% | -$388K |
|
648
Nasdaq
NDAQ
$52.9B
| $18.5M | 0.02% |
837,828
+35,838
| +4% | +$738K |
|
|
AMTD
649
DELISTED
TD Ameritrade Holding Corp
AMTD
| $18.3M | 0.02% |
581,507
-4,112
| -0.7% | -$121K |
|
|
ICPT
650
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $18.3M | 0.02% |
142,585
+5,843
| +4% | +$690K |
|
Similar funds
UBS AM's Q1 2016 Portfolio in Review
As of Q1 2016, UBS AM held 2,740 positions worth $86.2B, down 1.7% from $87.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q1 2016 filing shows 51 new, 583 increased, 1,774 reduced and 113 closed positions. Its largest new stake was NXP Semiconductors: 1,291,575 shares worth $105M. The largest sale was Thermo Fisher Scientific, an estimated $221M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q1 2016 buy was NXP Semiconductors: 1,291,575 shares worth $105M.
- UBS AM added most to Alibaba in Q1 2016, an estimated $235M increase.
- UBS AM's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $221M.
- UBS AM fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $97.5M.
- UBS AM's ten largest holdings make up 15% of its $86.2B portfolio in Q1 2016.
- UBS AM opened 51 new positions and closed 113 in Q1 2016.
- UBS AM's portfolio value fell 1.7% quarter-over-quarter to $86.2B.
Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.